Recurrent burpsespecially with diarrhea, vomiting, pain, weight loss, or GLP-1 treatmentneed a cause-based plan rather than a long list of unproven remedies
Semaglutide is a GLP-1 mono-agonist and tirzepatide is a GLP-1/GIP dual agonist
[20] Over the course of a 52 week double blind study to detect the efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes, the most common side effects seen were nausea, diarrhea, and vomiting [20]
If necessary, the dose can be further increased to 1 mg once a week after a minimum of four weeks on the 0.5 mg dose
So, if someone is having fewer meals or smaller meals, then they may also be hydrating less as a result
I take that seriously